The Claim
Growth hormone activates the MEK/ERK signaling pathway in human adipocytes, resulting in phosphorylation of PPARγ at Ser273, translocation of PPARγ from the nucleus to the cytoplasm, suppression of FSP27 transcription, and promotion of lipolysis.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Growth hormone triggers a sequence of molecular events in human fat cells that alters the location and activity of a key regulatory protein, leading to reduced production of a fat-storing protein and increased breakdown of fat.
See the scientific wording
Growth hormone activates the MEK/ERK signaling pathway in human adipocytes, leading to phosphorylation of PPARγ at Ser273 and its translocation from the nucleus to the cytoplasm, which suppresses transcription of FSP27 and promotes lipolysis.
Growth hormone binds to fat cells and turns on a signaling chain that modifies a key protein called PPARγ. This modification causes PPARγ to leave the nucleus, where it normally controls gene activity, and move into the cytoplasm. Without PPARγ in the nucleus, the cell stops making a protein called FSP27 that blocks fat breakdown. With FSP27 gone, stored fat is broken down and released as free fatty acids.
What the research says
1 studyStudy: Growth hormone acts along the PPARγ-FSP27 axis to stimulate lipolysis in human adipocytes.
Growth hormone tells fat cells to break down stored fat by flipping a molecular switch (PPARγ) that normally keeps fat from being broken down. When this switch is flipped, it stops making a protein that blocks fat breakdown, so the fat gets burned.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.